Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-020161

Exec. VP, European Commercial sold 1,297 shares at $16.64 ($21,588)

  • Exec. VP, European Commercial acquired 1,297 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Daniell Richard · Exec. VP, European Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-17 Exercise or conversion : show line 1 in the form +1,297 1,297 D
2019-03-18 Sale : show line 2 in the form −1,297 $16.64 $21,588 0 D
Open-market sales · 1,297 sh · avg $16.64 · $21,588

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-17 Exercise or conversion : show line 3 in the form Restricted Share Units −1,297 1,297 D
Loading xslF345X03/doc4.xml…